Campbell Aitken1, Cheryl Delalande, Kay Stanton. 1. The Macfarlane Burnet Centre for Medical Research, P.O. Box 254, Fairfield, 3078, Victoria, Australia. aitkenc@burnet.edu.au
Abstract
AIMS: To measure exposure to the hepatitis C and B viruses and HIV among Victorian steroid injectors and evaluate associations between exposure and risk behaviour, and report other characteristics of the study group. DESIGN: Seroprevalence study using a convenience sample. SETTING: Victoria, Australia. PARTICIPANTS: Current injectors of illicit anabolic steroids. MEASUREMENTS: Prevalences of exposure to HIV and the hepatitis B and C viruses; associations of characteristics and behaviours with exposure; descriptive statistics for the sample. FINDINGS: Six of 63 blood samples (9.5%) contained hepatitis C virus antibodies; 12.0% tested positive for hepatitis B core antibody; none contained anti-HIV. Hepatitis C virus exposure was associated with heroin injection, imprisonment, sharing needles to inject other drugs, number of tattoos, and hepatitis B virus exposure. No significant differences existed in the steroid-related risk behaviour of exposed and non-exposed individuals. Hepatitis B virus exposure was associated only with hepatitis C virus exposure, past imprisonment and age of first injection. CONCLUSIONS: Exposure to the hepatitis B and C viruses was detected; hepatitis C virus exposure was at much lower prevalence than normally found among other drug injectors. Factors other than steroid injecting were associated with exposure. Nonetheless, the hepatitis C-exposed reported many steroid-related and other risk behaviours which could spread the virus. Steroid injectors should not be neglected in blood-borne virus prevention efforts.
AIMS: To measure exposure to the hepatitis C and B viruses and HIV among Victorian steroid injectors and evaluate associations between exposure and risk behaviour, and report other characteristics of the study group. DESIGN: Seroprevalence study using a convenience sample. SETTING: Victoria, Australia. PARTICIPANTS: Current injectors of illicit anabolic steroids. MEASUREMENTS: Prevalences of exposure to HIV and the hepatitis B and C viruses; associations of characteristics and behaviours with exposure; descriptive statistics for the sample. FINDINGS: Six of 63 blood samples (9.5%) contained hepatitis C virus antibodies; 12.0% tested positive for hepatitis B core antibody; none contained anti-HIV. Hepatitis C virus exposure was associated with heroin injection, imprisonment, sharing needles to inject other drugs, number of tattoos, and hepatitis B virus exposure. No significant differences existed in the steroid-related risk behaviour of exposed and non-exposed individuals. Hepatitis B virus exposure was associated only with hepatitis C virus exposure, past imprisonment and age of first injection. CONCLUSIONS: Exposure to the hepatitis B and C viruses was detected; hepatitis C virus exposure was at much lower prevalence than normally found among other drug injectors. Factors other than steroid injecting were associated with exposure. Nonetheless, the hepatitis C-exposed reported many steroid-related and other risk behaviours which could spread the virus. Steroid injectors should not be neglected in blood-borne virus prevention efforts.
Authors: Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin Journal: Endocr Rev Date: 2013-12-17 Impact factor: 19.871
Authors: Emanuela Mhillaj; Maria G Morgese; Paolo Tucci; Maria Bove; Stefania Schiavone; Luigia Trabace Journal: Front Neurosci Date: 2015-08-26 Impact factor: 4.677
Authors: Kristen M Wheeler; Tony Antoniou; Sandra Gardner; Lucia Light; Ramandip Grewal; Jason Globerman; Winston Husbands; Ann N Burchell Journal: Am J Mens Health Date: 2017-03-01
Authors: Vivian D Hope; Jim McVeigh; Andrea Marongiu; Michael Evans-Brown; Josie Smith; Andreas Kimergård; Sara Croxford; Caryl M Beynon; John V Parry; Mark A Bellis; Fortune Ncube Journal: BMJ Open Date: 2013-09-12 Impact factor: 2.692